Who Owns NextCure Stock?
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 52.75%
- Held by insiders
- 8.64%
- Institutional holders
- 36
- Institutions 52.8%
- Insiders 8.6%
- Public and other 38.6%
Who owns NextCure stock?
Institutional investors own about 52.8% of NextCure's shares, spread across 36 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 8.64% of NXTC.
The largest institutional holders are Ikarian Capital, LLC (7.98%), Adage Capital Partners GP L.L.C. (7.67%) and Sofinnova Investments, Inc. (6.16%). Together, the top 10 institutions control 40.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their NXTC positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NXTC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Ikarian Capital, LLC | 288.30K | 7.98% | +21.0% |
| Adage Capital Partners GP L.L.C. | 277.20K | 7.67% | +100.0% |
| Sofinnova Investments, Inc. | 222.65K | 6.16% | 0.0% |
| Renaissance Technologies, LLC | 171.20K | 4.74% | +182.8% |
| Vanguard Capital Management LLC | 156.84K | 4.34% | -2.3% |
| Millennium Management Llc | 88.11K | 2.44% | +100.0% |
| Boothbay Fund Management, LLC | 84.69K | 2.34% | +21.6% |
| Squadron Capital Management LLC | 64.46K | 1.78% | -75.7% |
| Verdad Advisers, LP | 60.45K | 1.67% | +40.7% |
| Pfizer Inc | 44.35K | 1.23% | -71.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NXTC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 123.28K | 3.41% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 33.57K | 0.93% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 16.25K | 0.45% |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 12.50K | 0.35% |
| iShares Trust-iShares Micro-Cap ETF | 9.79K | 0.27% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 4.00K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 3.63K | 0.10% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 741 | 0.02% |
| Master Investment Portfolio-Diversified Equity Alpha Master Portfolio | 689 | 0.02% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 59 | 0.00% |
Frequently asked questions
Who is the largest shareholder of NextCure?
Ikarian Capital, LLC is the largest institutional shareholder of NXTC, owning 7.98% of shares outstanding (288.30K shares) as of its latest 13F filing.
What percentage of NextCure is owned by institutions?
Institutions own about 52.8% of NXTC shares and 57.7% of the public float.
How much of NextCure do insiders own?
Insiders, such as officers and directors, own about 8.64% of NXTC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.